Transgenic mouse lines were engineered to express stably antisense mRN
A or antisense mRNA containing catalytic ribozyme (rbz) structures com
plementary to bacterial chloramphenicol acetyltransferase (CAT) gene t
ranscripts. One transgenic line expressed antisense mRNA that specific
ally targeted full-length CAT coding sequences (ACAT). Another transge
nic line expressed full-length antisense CAT mRNA which was modified b
y mutagensis to include four rbz cassettes (rbz-ACAT) in order to comp
are antisense versus antisense-rbz function in vivo. Preliminary data
were also collected from a transgenic mouse line expressing antisense
mRNA targeting 72% of the 5' region of CAT coding sequences (5' ACAT).
All constructs contained similar control elements in their design. Pr
omoter elements were derived from the bovine alpha(s1)-casein gene, wh
ile the small t intron and 3' control sequences were derived from SV40
. The ability of these various constructs to down-regulate CAT protein
levels was compared by analysis of CAT protein production in lactatin
g double-hemizygous transgenic female mice. Every double-hemizygous mo
use analysed expressed mRNA from the alpha(s1)-casein-CAT construct (C
larke et al., 1994) and equivalent levels of mRNA from one of the thre
e antisense constructs. Transgenic mouse lines expressing both ACAT an
d CAT mRNA down-regulated CAT protein levels by 90% of that found in t
he CAT only transgenic population. Similarly, double-hemizygous transg
enic lines expressing both rbz-ACAT and CAT mRNA regulated CAT protein
levels by 87%. Preliminary data suggests that expression of mRNA from
5' ACAT/CAT double-hemizygote mice allowed approximately 67% down-reg
ulation of normal CAT protein levels. We conclude that incorporation o
f multiple ribozymes within the full-length antisense CAT construct do
es not enhance the effectiveness of antisense mRNA in the down-regulat
ion of CAT protein production in our system.